KEGG   DRUG: Emtricitabine and tenofovir disoproxil
Entry
D02297            Mixture   Drug                                   

Name
Emtricitabine and tenofovir disoproxil;
Truvada (TN)
Product
  Generic
Component
Emtricitabine [DR:D01199], (Tenofovir disoproxil fumarate [DR:D01982] | Tenofovir disoproxil phosphate [DR:D10834])
Remark
Therapeutic category: 6250
ATC code: J05AR03
Product: D02297<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
RNA-directed DNA polymerase
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR03 Tenofovir disoproxil and emtricitabine
      D02297  Emtricitabine and tenofovir disoproxil <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Emtricitabine/ Tenofovir Disoproxil Fumarate
    D02297  Emtricitabine and tenofovir disoproxil
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D02297  Emtricitabine and tenofovir disoproxil
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D02297
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D02297
Other DBs
PubChem: 7849356

» Japanese version   » Back

  All links  
Ontology (5)   
   KEGG BRITE (5)   
Disease (1)   
   KEGG DISEASE (1)   
Chemical substance (1)   
   PubChem (1)   
All databases (7)   

Download RDF
DBGET integrated database retrieval system